Here are relevant reports on : hepatitis-c-market
-
Infectious Disease Immunoassay Market by Product & Services (Reagents and kits, Analysers & Software and Services), Platform (CLIA, FIA, CI, RIA), Specimen Type, Disease (Hepatitis, HIV, CT/NG, HPV, TB, Influenza) & End User - Global Forecast to 2023
The global infectious disease immunoassay market is expected to reach USD 2,233.0 million by 2023 from USD 1,642.5 million in 2018, growing at a CAGR of 6.3%. Increasing incidence of chronic and infectious diseases; technological advancements in immunoassay instruments and the introduction of novel automated systems; growth in biotechnology and biopharmaceutical industries; increasing adoption of immunoassay-based point-of-care testing and rapid testing are some of the major factors driving the growth of the global infectious disease immunoassay market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Asia Pacific molecular diagnostics market, valued at US$3.85 billion in 2025, stood at US$4.22 billion in 2026 and is projected to advance at a resilient CAGR of 12.4% from 2026 to 2031, culminating in a forecasted valuation of US$7.58 billion by the end of the period. The Asia Pacific molecular diagnostics market is experiencing significant growth as healthcare systems across the region are increasingly focusing on enhancing the accuracy of diagnosis and increasing access to diagnostic testing.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Point-of-Care Molecular Diagnostics Market by Product & Service (Assays, Instruments, Software), Technology (RT-PCR, INAAT), Sample Type (Blood, Urine), Application (STD, HAI, Hepatitis, Cancer), and End User (Hospitals, Clinics) - Global Forecast to 2030
The global point-of-care molecular diagnostics market, valued at US$4.01 billion in 2024, stood at US$4.30 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of US$7.09 billion by the end of the period. The market is experiencing strong growth due to increasing demand for timely and accessible testing solutions. A major factor is the rising prevalence of infectious diseases and cancer, which has created a growing need for fast and reliable diagnostics.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, PCR, NGS), Disease (Hepatitis, HIV, HAI, TB, Flu, Syphilis), End User (Labs) - Global Forecast to 2030
The global infectious disease diagnostics market, valued at US$24.96 billion in 2024, stood at US$26.58 billion in 2025 and is projected to advance at a resilient CAGR of 9.7% from 2025 to 2030, culminating in a forecasted valuation of US$40.20 billion by the end of the period. The key growth drivers include the increasing prevalence of infectious diseases, the rising demand for early & accurate diagnosis, and continuous advancements in diagnostic technologies.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
The global molecular diagnostics market, valued at USD 18.29 billion in 2024, stood at USD 19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of USD 30.74 billion by the end of the period. The Asia Pacific market is projected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and rapid expansion of medical infrastructure in Asia Pacific countries.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Middle East & Africa molecular diagnostics market, valued at USD 0.32 billion in 2025, stood at USD 0.33 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.47 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
The global isothermal nucleic acid amplification technology market, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 9.2% from 2023 to 2028, culminating in a forecasted valuation of US$6.8 billion by the end of the period. The growth of the market is attributed to the cost-benefits of INAAT, rising prevalence of infectious diseases, and increasing number of blood transfusions and donations.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Europe Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Europe molecular diagnostics market, valued at US$5.60 billion in 2025, stood at US$6.05 billion in 2026 and is projected to advance at a resilient CAGR of 10.9% from 2026 to 2031, culminating in a forecasted valuation of US$10.15 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Latin America Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Latin America molecular diagnostics market, valued at US$0.72 billion in 2025, stood at US$0.76 billion in 2026 and is projected to advance at a resilient CAGR of 8.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.16 billion by the end of the period. This growth can be attributed to the rising demand for reliable diagnostic results, especially in infectious diseases & chronic illnesses like cancer.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Automated Guided Vehicle (AGV) Market by Type (Tow Vehicles, Unit Load Carriers, Pallet Trucks, Assembly Line Vehicles, Forklift Trucks), Navigation Technology (Laser, Magnetic, Inductive, Optical Tape, Vision) – Forecast to 2032
Europe Automated Guided Vehicle (AGV) Market
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
